These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28502092)

  • 1. HIV/HCV coinfection and the risk of cardiovascular disease: A meta-analysis.
    Osibogun O; Ogunmoroti O; Michos ED; Spatz ES; Olubajo B; Nasir K; Madhivanan P; Maziak W
    J Viral Hepat; 2017 Nov; 24(11):998-1004. PubMed ID: 28502092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the associations between HIV/HCV coinfection and biomarkers of cardiovascular disease.
    Osibogun O; Ogunmoroti O; Michos ED; Spatz ES; Olubajo B; Nasir K; Maziak W
    Rev Med Virol; 2018 Jan; 28(1):. PubMed ID: 29135056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Med Virol; 2016 Mar; 88(3):487-97. PubMed ID: 26271205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection.
    Lang R; Humes E; Hogan B; Lee J; D'Agostino R; Massaro J; Kim A; Meigs JB; Borowsky L; He W; Lyass A; Cheng D; Kim HN; Klein MB; Cachay ER; Bosch RJ; Gill MJ; Silverberg MJ; Thorne JE; McGinnis K; Horberg MA; Sterling TR; Triant VA; Althoff KN
    J Am Heart Assoc; 2022 Oct; 11(19):e026473. PubMed ID: 36129038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.
    Stafford KA; Rikhtegaran Tehrani Z; Saadat S; Ebadi M; Redfield RR; Sajadi MM
    Medicine (Baltimore); 2017 Jun; 96(26):e7348. PubMed ID: 28658155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
    Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
    Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women.
    Cedarbaum E; Ma Y; Scherzer R; Price JC; Adimora AA; Bamman M; Cohen M; Fischl MA; Matsushita K; Ofotokun I; Plankey M; Seaberg EC; Yin MT; Grunfeld C; Vartanian S; Sharma A; Tien PC
    AIDS; 2019 Nov; 33(13):2025-2033. PubMed ID: 31335806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.
    Tan BK; Chalouni M; Ceron DS; Cinaud A; Esterle L; Loko MA; Katlama C; Poizot-Martin I; Neau D; Chas J; Morlat P; Rosenthal E; Lacombe K; Naqvi A; Barange K; Bouchaud O; Gervais A; Lascoux-Combe C; Garipuy D; Alric L; Goujard C; Miailhes P; Aumaitre H; Duvivier C; Simon A; Lopez-Zaragoza JL; Zucman D; Raffi F; Lazaro E; Rey D; Piroth L; Boué F; Gilbert C; Bani-Sadr F; Dabis F; Sogni' P; Wittkop L; Boccara F;
    Clin Infect Dis; 2021 May; 72(9):e215-e223. PubMed ID: 32686834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community.
    Shitole SG; Kuniholm MH; Hanna DB; Boucher T; Peng AY; Berardi C; Shah T; Bortnick AE; Christia P; Scheuer J; Kizer JR
    Atherosclerosis; 2020 Oct; 311():60-66. PubMed ID: 32947199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-Analysis.
    Martinello M; Amin J; Matthews GV; Dore GJ
    AIDS Rev; 2016; 18(2):68-80. PubMed ID: 27196354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.
    Alvaro-Meca A; Berenguer J; Díaz A; Micheloud D; Aldámiz-Echevarría T; Fanciulli C; Resino S
    PLoS One; 2017; 12(6):e0179493. PubMed ID: 28617855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological Mechanisms in the Coinfection between HIV and HCV.
    Liberto MC; Zicca E; Pavia G; Quirino A; Marascio N; Torti C; Focà A
    Mediators Inflamm; 2015; 2015():320532. PubMed ID: 26494946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
    PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated and Premature Aging Characterizing Regional Cortical Volume Loss in Human Immunodeficiency Virus Infection: Contributions From Alcohol, Substance Use, and Hepatitis C Coinfection.
    Pfefferbaum A; Zahr NM; Sassoon SA; Kwon D; Pohl KM; Sullivan EV
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Oct; 3(10):844-859. PubMed ID: 30093343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.